|
James, L; Ito, S (2009) Neonatal pharmacology: rational therapeutics for the most vulnerable. Clin Pharmacol Ther 86:573-7
|
|
James, L P; Wilson, J T; Simar, R et al. (2001) Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila) 40:243-8
|
|
Gaedigk, A; Casley, W L; Tyndale, R F et al. (2001) Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations. Can J Physiol Pharmacol 79:841-7
|
|
Gaedigk, A (2000) Interethnic differences of drug-metabolizing enzymes. Int J Clin Pharmacol Ther 38:61-8
|
|
Gaedigk, A; Gotschall, R R; Forbes, N S et al. (1999) Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics 9:669-82
|
|
Marshall, J D; Kearns, G L (1999) Developmental pharmacodynamics of cyclosporine. Clin Pharmacol Ther 66:66-75
|
|
Marshall, J D; Abdel-Rahman, S; Johnson, K et al. (1999) Rifapentine pharmacokinetics in adolescents. Pediatr Infect Dis J 18:882-8
|
|
James, L P; Stowe, C D; Farrar, H C et al. (1999) The pharmacokinetics of oral ranitidine in children and adolescents with cystic fibrosis. J Clin Pharmacol 39:1242-7
|
|
Wells, T G (1999) Trials of antihypertensive therapies in children. Blood Press Monit 4:189-92
|
|
Marshall, J D; Wells, T G; Letzig, L et al. (1998) Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients. J Clin Pharmacol 38:994-1002
|
Showing the most recent 10 out of 16 publications
